MedinCell
Short position disclosed on September 21, 2026.
Evolution of the disclosed total
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Jpmorgan Asset Management (UK) Limited | 0.69% | new | June 23, 2026 | AMF | |
| Arrowstreet Capital, Limited Partnership | 0.51% | new | September 21, 2026 |
In the United States MDCLF (OTC): 43,380 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold MedinCell Titelia
Get the moves on MedinCell by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
The AMF column opens the filing the fund itself lodged, on the regulator own site.
Download 27 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Ubisoft Entertainment 12.49% of the capital sold short
- Valeo 11.40% of the capital sold short
- Renault 9.16% of the capital sold short
- Viridien 8.08% of the capital sold short
- Teleperformance 7.58% of the capital sold short
- FDJ United 6.19% of the capital sold short
- Abivax 5.10% of the capital sold short
- Elis 4.91% of the capital sold short
- Alstom 4.57% of the capital sold short
- Rémy Cointreau 4.46% of the capital sold short
- Sopra Steria Group 3.92% of the capital sold short
- Spie SA 3.75% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, MedinCell, source AMF, data as at September 21, 2026, https://www.quivad.com/action/medincell